-
Pediatric Oncologists Underestimate Needs of Minority Parents
Research describes how communication gaps can shift extra burden to parents who are members of ethnic and racial minority groups.
by Marci A. Landsmann
-
Why Skip a Dose?
A survey of over 1,000 breast cancer patients prescribed endocrine therapy sheds light on low adherence.
by Emma Yasinski
-
When COVID-19 Comes Home
I have brain cancer, and my wife is a health care worker. These are some questions we had to consider leading up to and after her diagnosis with COVID-19.
by Adam Hayden
-
What It’s Like to Get a “C” in Graduate School
I was afraid that my thyroid cancer diagnosis would derail my graduate school plans. Instead, it helped shape my career path.
by Carly Flumer
-
Tumor Testing May Help Guide Pancreatic Cancer Treatment
For a small group of pancreatic cancer patients who were able to receive therapies targeting the molecular alterations in their tumors, these matched therapies were associated with longer life.
by Cheryl Platzman Weinstock
-
Facing Cancer and a Pandemic at the Same Time
Cancer patients and their families share stories of fear, love and uncertainty as they find new ways to support each other.
by Jen Tota McGivney
-
Virtual Connection in a Time of Social Distance
Responding to the coronavirus, patient advocates and nonprofits expand existing outreach initiatives and launch new ones.
by Marci A. Landsmann
-
A Unified Strategy
A couple who lost their daughter to brain cancer builds a charity that connects parents, hospitals and researchers with data.
by Marci A. Landsmann
-
Caregiving With Confidence
Strategies for Effective CommunicationWhen families work together to provide care for a loved one, communicating can become a challenge.
by Ashley Jones
Cancer Talk
Treating Smoldering Multiple Myeloma
A monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona